Tudor Investment Corp ET AL Acquires Shares of 75,134 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Tudor Investment Corp ET AL acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 75,134 shares of the medical instruments supplier's stock, valued at approximately $1,426,000.

A number of other institutional investors also recently added to or reduced their stakes in XRAY. Pacer Advisors Inc. boosted its position in DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. Nuance Investments LLC raised its stake in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after buying an additional 2,708,097 shares during the last quarter. Norges Bank purchased a new stake in DENTSPLY SIRONA in the fourth quarter valued at about $45,730,000. Price T Rowe Associates Inc. MD raised its stake in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after buying an additional 1,975,404 shares during the last quarter. Finally, Cooke & Bieler LP raised its stake in DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after buying an additional 1,794,391 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

XRAY stock traded down $0.10 during trading on Friday, hitting $15.81. 4,397,789 shares of the company traded hands, compared to its average volume of 2,959,440. The stock's 50-day simple moving average is $14.36 and its 200 day simple moving average is $17.54. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The company has a market cap of $3.15 billion, a PE ratio of -7.64, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $28.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA's quarterly revenue was down 7.8% on a year-over-year basis. During the same period last year, the business earned $0.42 earnings per share. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.05%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Barrington Research decreased their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target for the company. in a research note on Tuesday, April 15th. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Jefferies Financial Group cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating and decreased their price target for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Finally, Robert W. Baird decreased their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of "Hold" and an average price target of $20.27.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.